|
|
|
Insider
Information: |
Ra Capital Biotech Fund Lp |
Relationship: |
10% Owner |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
10 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
50,143,338 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$1,000,277,130 |
|
|
Total
Shares |
50,143,338 |
|
|
Total
Value |
$1,000,277,130 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Aradigm Corp |
ARDM |
10% Owner |
|
0 |
2007-01-24 |
6,355,000 |
Premium* |
|
Curis Inc |
CRIS |
10% Owner |
|
0 |
2007-08-08 |
7,520,564 |
Premium* |
|
Biospecifics Technologies Corp |
BSTC |
10% Owner |
2010-02-03 |
0 |
2010-02-23 |
636,462 |
Premium* |
|
Derma Sciences Inc |
DSCI |
Fmr 10% Owner - See Fn... |
|
0 |
2014-01-10 |
1,694,876 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
Former 10% Owner, See ... |
2013-09-30 |
0 |
2014-09-30 |
6,700,000 |
Premium* |
|
Dicerna Pharmaceuticals Inc |
DRNA |
10% Owner |
2014-02-04 |
0 |
2017-12-18 |
5,074,013 |
Premium* |
|
Aclaris Therapeutics, Inc. |
ACRS |
10% Owner |
2015-10-22 |
0 |
2016-09-16 |
2,102,169 |
Premium* |
|
Wave Life Sciences Ltd. |
WVE |
Director, 10% Owner |
|
0 |
2015-11-16 |
7,088,651 |
Premium* |
|
Synthorx, Inc. |
THOR |
10% Owner |
2018-12-11 |
0 |
2018-12-11 |
9,724,598 |
Premium* |
|
Scpharmaceuticals Inc. |
SCPH |
10% Owner |
2019-04-11 |
0 |
2019-04-11 |
3,247,005 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ARDM |
Aradigm Corp |
10% Owner |
|
2007-01-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,355,000 |
|
- |
|
CRIS |
Curis Inc |
10% Owner |
|
2007-08-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,520,564 |
|
- |
|
DSCI |
Derma Sciences Inc |
10% Owner |
|
2013-04-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,990,931 |
|
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-09-30 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
11,657,061 |
|
- |
|
WVE |
Wave Life Sciences Ltd. |
Director |
|
2015-11-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,041,591 |
|
- |
|
DRNA |
Dicerna Pharmaceuticals I... |
10% Owner |
|
2014-02-04 |
4 |
A |
$0.00 |
$0 |
I/I |
1,428,571 |
1,428,571 |
0 |
- |
|
WVE |
Wave Life Sciences Ltd. |
Director |
|
2015-11-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,172,060 |
5,213,651 |
0 |
- |
|
DRNA |
Dicerna Pharmaceuticals I... |
10% Owner |
|
2017-12-18 |
4 |
OE |
$0.00 |
$0 |
I/I |
2,645,442 |
5,074,013 |
0 |
- |
|
THOR |
Synthorx, Inc. |
10% Owner |
|
2018-12-11 |
4 |
A |
$0.00 |
$0 |
I/I |
5,179,143 |
5,179,143 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
See Footnotes (1)-(5) |
|
2013-10-31 |
4 |
B |
$2.30 |
$2,902,711 |
I/I |
1,186,007 |
20,461,007 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
See Footnotes (1)-(9) |
|
2013-10-11 |
4 |
B |
$2.50 |
$6,279,017 |
I/I |
2,448,710 |
16,905,771 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
See Footnotes (1)-(5) |
|
2013-11-20 |
4 |
B |
$2.53 |
$2,826,275 |
I/I |
1,110,000 |
23,366,007 |
1.5 |
- |
|
SCPH |
Scpharmaceuticals Inc. |
10% Owner |
|
2019-04-11 |
4 |
B |
$2.70 |
$1,052,627 |
I/I |
389,862 |
3,247,005 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
See Footnotes (1)-(9) |
|
2013-10-14 |
4 |
B |
$2.76 |
$6,615,932 |
I/I |
2,369,229 |
19,275,000 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
See Footnotes (1)-(7) |
|
2013-09-30 |
4 |
B |
$2.96 |
$8,354,088 |
I/I |
2,800,000 |
14,457,061 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2014-08-15 |
4 |
S |
$9.34 |
$21,069,423 |
I/I |
(2,241,022) |
20,244,985 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2014-08-18 |
4 |
S |
$9.51 |
$19,279,545 |
I/I |
(1,993,978) |
18,251,007 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
Former 10% Owner, See FN(5)(6) |
|
2014-09-30 |
4 |
S |
$10.02 |
$11,163,819 |
I/I |
(1,111,000) |
6,700,000 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2014-09-26 |
4 |
S |
$10.96 |
$7,424,790 |
I/I |
(670,000) |
8,032,014 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
Former 10% Owner, See FN(5)(6) |
|
2014-09-29 |
4 |
S |
$10.96 |
$2,423,264 |
I/I |
(221,014) |
7,811,000 |
0 |
- |
|
THOR |
Synthorx, Inc. |
10% Owner |
|
2018-12-11 |
4 |
B |
$11.00 |
$50,000,005 |
I/I |
4,545,455 |
9,724,598 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2014-09-25 |
4 |
S |
$11.01 |
$5,501,745 |
I/I |
(497,986) |
8,702,014 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2014-09-23 |
4 |
S |
$11.02 |
$10,909,010 |
I/I |
(984,522) |
10,404,929 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2014-09-22 |
4 |
S |
$11.08 |
$4,940,414 |
I/I |
(445,689) |
11,389,451 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2014-09-24 |
4 |
S |
$11.24 |
$13,574,954 |
I/I |
(1,204,929) |
9,200,000 |
0 |
- |
|
47 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|